Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

11,824 public trials 2,516 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

NCT07226427

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

INSPIRE: INnovative SABR for Prostate Cancer All IREland

NCT07552168

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • St Luke's Centre for Radiation Oncology at Beaumont Hospital Dublin, Leinster, Ireland
  • Bon Secours - UPMC Hillman Cork, Ireland
  • UPMC Hillman Cancer Centre at Whitfield Hospital Waterford, Ireland
  • Northern Ireland Cancer Centre (NICC) Belfast, Ulster, United Kingdom
View Trial Details
Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

NCT07319871

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • The Christie NHS Foundation Trust Christie Hospital Manchester, United Kingdom
View Trial Details
Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT05739981

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Johns Hopkins Medicine SKCCC Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OU Health, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View Trial Details
Recruiting

Predicting BCG Response

NCT04564781

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • University of Texas Southwestern Dallas, Texas, United States
View Trial Details

Related conditions